Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study.

H Erdem, O Ak, N Elaldi, T Demirdal, S Hargreaves, S A Nemli, Y Cag, M Ulug, H Naz, O Gunal, F Sirmatel, O R Sipahi, S N Alpat, G Ertem-Tuncer, H Sozen, O Evlice, M Meric-Koc, A Dogru, V Koksaldi-Motor, R Tekin, D Ozdemir, D Ozturk-Engin, U Savasci, E Karagoz, Y Cekli, A Inan
Author Information
  1. H Erdem: Department of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Ankara, Turkey. hakanerdem1969@yahoo.com.
  2. O Ak: Department of Infectious Diseases and Clinical Microbiology, Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
  3. N Elaldi: Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University School of Medicine, Sivas, Turkey.
  4. T Demirdal: Department of Infectious Diseases and Clinical Microbiology, Katip Celebi University School of Medicine, Izmir, Turkey.
  5. S Hargreaves: International Health Unit, Section of Infectious Diseases and Immunity, Imperial College London, Commonwealth Building, Hammersmith Campus, London, UK.
  6. S A Nemli: Department of Infectious Diseases and Clinical Microbiology, Katip Celebi University School of Medicine, Izmir, Turkey.
  7. Y Cag: Goztepe Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Istanbul, Turkey.
  8. M Ulug: Department of Infectious Diseases and Clinical Microbiology, Private Umit Hospital, Eskisehir, Turkey.
  9. H Naz: Department of Infectious Diseases and Clinical Microbiology, Kocaeli State Hospital, Kocaeli, Turkey.
  10. O Gunal: Department of Infectious Diseases and Clinical Microbiology, Samsun Training and Research Hospital, Samsun, Turkey.
  11. F Sirmatel: School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Abant Izzet Baysal University, Bolu, Turkey.
  12. O R Sipahi: Department of Infectious Diseases and Clinical Microbiology, Ege University School of Medicine, Izmir, Turkey.
  13. S N Alpat: Department of Infectious Diseases and Clinical Microbiology, Osmangazi University School of Medicine, Eskisehir, Turkey.
  14. G Ertem-Tuncer: Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey.
  15. H Sozen: Department of Infectious Diseases and Clinical Microbiology, Mugla Sitki Kocman University School of Medicine, Mugla, Turkey.
  16. O Evlice: Department of Infectious Diseases and Clinical Microbiology, Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
  17. M Meric-Koc: Department of Infectious Diseases and Clinical Microbiology, Kocaeli University School of Medicine, Izmit, Turkey.
  18. A Dogru: Goztepe Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Istanbul, Turkey.
  19. V Koksaldi-Motor: Tayfur Ata Sokmen School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Mustafa Kemal University, Hatay, Turkey.
  20. R Tekin: Department of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey.
  21. D Ozdemir: Department of Infectious Diseases and Clinical Microbiology, Duzce University School of Medicine, Konuralp, Duzce, Turkey.
  22. D Ozturk-Engin: Department of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  23. U Savasci: Department of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Ankara, Turkey.
  24. E Karagoz: Department of Infectious Diseases and Clinical Microbiology, Military Hospital, Van, Turkey.
  25. Y Cekli: Department of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Ankara, Turkey.
  26. A Inan: Department of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

Abstract

Mass gatherings pooling people from different parts of the world-the largest of which is to Mecca, Saudi Arabia, for Hajj-may impose risks for acquisition and dissemination of infectious diseases. A substantial number of pilgrims to Hajj and Umrah are Turkish citizens (456,000 in 2014) but data are lacking on scale of the problem. We did a retrospective cross-sectional multicenter study in Turkey to explore the range of infections among inpatients who had recently returned from the Arabian Peninsula. Our inclusion criteria were patients who had acquired an infection during their trip to an Arabian Peninsula country, or who became symptomatic within 1 week of their return. The data were collected retrospectively for January 1, 2013 and March 1, 2015. 185 Turkish patients were recruited to the study across 15 referral centers with travel associated infectious diseases after returning from Arabian Peninsula countries (predominantly Saudi Arabia 163 [88.1 %] for religious purposes 162 [87.5 %]). Seventy four (40.0 %) of them were ≥ 65 years old with numerous comorbidities including diabetes (24.3 %) and COPD (14.1 %). The most common clinical diagnosis was respiratory tract infections (169 [91.5 %]), followed by diarrheal diseases (13 [7 %]), and there was one case of MERS-CoV. Patients spent a median of 5 (3-7) days as hospital inpatients and overall mortality was 1.1 %. Returning travellers from the Arabian Peninsula present as inpatients with a broad range of infectious diseases similar to common community acquired infections frequently seen in daily medical practices in Turkey.

References

  1. Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1591-9 [PMID: 24789652]
  2. Clin Microbiol Infect. 2015 Jul;21(7):650.e5-8 [PMID: 25882367]
  3. Int J Antimicrob Agents. 2015 Jun;45(6):600-4 [PMID: 25769786]
  4. J Infect. 2014 Feb;68(2):131-40 [PMID: 24269951]
  5. Pediatr Clin North Am. 2009 Feb;56(1):101-17, x [PMID: 19135583]
  6. Emerg Infect Dis. 2014 Apr;20(4):728-30 [PMID: 24656283]
  7. N Engl J Med. 2013 Jun 27;368(26):2487-94 [PMID: 23718156]
  8. J Travel Med. 2000 Sep-Oct;7(5):259-66 [PMID: 11231210]
  9. Lancet. 2014 Jun 14;383(9934):2073-2082 [PMID: 24857703]
  10. J Neurol. 2015;262(4):890-8 [PMID: 25634680]
  11. Euro Surveill. 2012 Oct 11;17(41):20295 [PMID: 23078811]
  12. N Engl J Med. 2006 Jan 12;354(2):119-30 [PMID: 16407507]
  13. Am Fam Physician. 2006 Feb 1;73(3):442-50 [PMID: 16477891]
  14. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72 [PMID: 17278083]
  15. Vaccine. 2015 May 21;33(22):2562-9 [PMID: 25887084]
  16. Saudi Med J. 2015 Apr;36(4):393-8 [PMID: 25828274]
  17. Antimicrob Agents Chemother. 2012 Mar;56(3):1523-8 [PMID: 22155822]
  18. J Infect Dis. 1987 Jul;156(1):84-91 [PMID: 3598228]
  19. Travel Med Infect Dis. 2015 Nov-Dec;13(6):485-9 [PMID: 26464001]
  20. Clin Microbiol Infect. 2015 Jun;21(6):571.e1-8 [PMID: 25700892]
  21. Virol Sin. 2014 Dec;29(6):364-71 [PMID: 25413828]
  22. N Engl J Med. 2013 Aug 1;369(5):407-16 [PMID: 23782161]
  23. Ann Clin Microbiol Antimicrob. 2011 Dec 16;10:38 [PMID: 22177310]
  24. Trop Med Int Health. 2015 Jun;20(6):807-12 [PMID: 25688471]
  25. J Crit Care. 2013 Dec;28(6):975-9 [PMID: 24075301]
  26. Lancet Infect Dis. 2013 Sep;13(9):752-61 [PMID: 23891402]
  27. Clin Microbiol Infect. 2012 Nov;18(11):1056-67 [PMID: 23043613]

MeSH Term

Comorbidity
Critical Care
Cross-Sectional Studies
Female
Follow-Up Studies
Humans
Infections
Intensive Care Units
Male
Microbiological Techniques
Middle East
Retrospective Studies
Serologic Tests
Travel
Turkey

Word Cloud

Created with Highcharts 10.0.0ArabiandiseasesPeninsulainfectiousstudyTurkeyinfectionsinpatients1SaudiArabiaTurkishdataretrospectivecross-sectionalmulticenterrangepatientsacquiredreturning5 %]1 %commontravellersMassgatheringspoolingpeopledifferentpartsworld-thelargestMeccaHajj-mayimposerisksacquisitiondisseminationsubstantialnumberpilgrimsHajjUmrahcitizens4560002014lackingscaleproblemexploreamongrecentlyreturnedinclusioncriteriainfectiontripcountrybecamesymptomaticwithin1 weekreturncollectedretrospectivelyJanuary2013March2015185recruitedacross15referralcenterstravelassociatedcountriespredominantly163[881 %]religiouspurposes162[87Seventyfour400 %were ≥ 65 yearsoldnumerouscomorbiditiesincludingdiabetes243 %COPD14clinicaldiagnosisrespiratorytract169[91followeddiarrheal13[7 %]onecaseMERS-CoVPatientsspentmedian53-7dayshospitaloverallmortalityReturningpresentbroadsimilarcommunityfrequentlyseendailymedicalpracticesInfectionspeninsula:

Similar Articles

Cited By